APT Medical 惠泰医疗
2 significant filings since 31 May 2026: 1 on major holder selling and 1 on guarantee or financial assistance. The latest, on 21 Sep 2026: 关于持股5%以上股东减持计划的公告.
自 31 May 2026 起有 2 份重大公告：major holder selling 1 份、guarantee or financial assistance 1 份。最新一份（21 Sep 2026）：关于持股5%以上股东减持计划的公告。
The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平：同期 99.3% 的评级为买入或跑赢。 Every rated report on this company said Buy or Outperform.
| Date 日期 | Broker 券商 | Analyst 分析师 | From 原评级 | To 新评级 | |
|---|---|---|---|---|---|
| 24 Apr 2025 | 国信证券 | 陈曦炳,彭思宇,张超 | Buy 买入 | ▼ | Outperform 增持 |
| 25 Aug 2023 | 国金证券 | 袁维,何冠洲 | Outperform 增持 | ▲ | Buy 买入 |
Each broker's rating is compared with its previous report. 每家券商的评级与其上一份研报比较。
| Broker 券商 | Analyst 分析师 | Latest Rating 最新评级 | Date 日期 | Reports 研报 | Target 目标价 |
|---|---|---|---|---|---|
| 东吴证券 | 朱国广 | Buy 买入 | 5 Sep 2026 | 2 | — |
| 国信证券 | 陈曦炳,彭思宇,贾瑞祥 | Outperform 增持 | 21 Aug 2026 | 2 | — |
| 太平洋 | 谭紫媚 | Buy 买入 | 21 Aug 2026 | 3 | — |
| 国金证券 | 甘坛焕,何冠洲 | Buy 买入 | 20 Aug 2026 | 5 | — |
| 西南证券 | 杜向阳,陈辰 | Outperform 增持 | 31 Mar 2026 | 1 | — |
Each row is a broker's latest report in the last twelve months. A price target is given in 0 of 13 reports. 每行为该券商近十二个月的最新研报；13 份中 0 份给出目标价。
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。